Search For "biologics"
Biocon Biologics gets U.S. FDA approval for biosimilar aflibercept Yesafil
Updated : 1 year, 9 months ago IST
Biocon Biologics announced that the U.S. Food and Drug Administration (US FDA) has approved the company's application for YESAFILI, the company informed the exchange in a filing.
Read More
Kemwell BioPharma Drives Quality Excellence with Veeva Vault QMS
Updated : 1 year, 11 months ago IST
Bangalore (Karnataka) [India], April 2: Veeva Systems (NYSE: VEEV) today announced that Kemwell BioPharma, India's largest biologics contract development and manufacturing organization (CDMO), has swiftly implemented the Veeva Vault Quality Management System (QMS) across its development and
Read More
Takeda Accelerates Access to its Dengue Vaccine Through 'Make in India' Ma
Updated : 2 years ago IST
Singapore, February 27: Takeda (TSE:4502/NYSE:TAK) today announced a strategic partnership with Biological E. Limited, a leading vaccines and biologics company in India, to manufacture Takeda's dengue vaccine, TAK-003. The partnership marks a crucial step in the fight against the global publ
Read More
Algorithmic Biologics make Genomics affordable eliminating 60 to 90 per ce
Updated : 2 years, 1 month ago IST
New Delhi [India], February 5: Deeptech startup Algorithmic Biologics (AlgoBio), leveraging advanced algorithms and AI to revolutionize molecular testing efficiency and scale, unveiled the Tapestry platform for next-generation sequencing (NGS) at Genomics India Conference 2024 today. Aligned
Read More
Glenmark and Ichnos take a collaborative leap to accelerate innovation in
Updated : 2 years, 1 month ago IST
Mumbai (Maharashtra) [India], January 31: Glenmark Pharmaceuticals Ltd. (Glenmark), a leading, research-driven, global pharmaceutical company, and Ichnos Sciences Inc. (Ichnos), its global fully integrated, clinical-stage biotech subsidiary, today announced the launch of their alliance - Ich
Read More
Zumutor Biologics Inc announces FDA clearance of IND application of ZM008,
Updated : 2 years, 7 months ago IST
Boston [US]/Bangalore (Karnataka) [India], August 11: Zumutor Biologics Inc "Zumutor", a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today announces that the US Food and Drug Administration (FDA) has granted the company's In
Read More
UFO hearing: Whistleblower testifies, claims US has possession of 'nonhuma
Updated : 2 years, 7 months ago IST
Unidentified flying object (UFO) whistleblower, who claimed that the US government is secretly holding alien spacecraft, gave evidence to the Congress on Wednesday.
Read More
No impact on industry of move to withdraw Rs 2000 notes from circulation:
Updated : 2 years, 9 months ago IST
Mittal told ANI in an interview that a large portion of retail sales in pharmacies happen through digital modes
Read More
Dr Devi Shetty and Kiran Mazumdar Shaw Inaugurated 10-Bedded BMT Unit at M
Updated : 3 years, 1 month ago IST
Bengaluru (Karnataka) [India], February 3 (ANI/NewsVoir): With a vision to strengthen its presence in cancer care solutions in Karnataka region, Dr Devi Shetty, Chairman & Executive Director, Narayana Health and Kiran Mazumdar Shaw, Executive Chairperson - Biocon Limited and Biocon Biolo
Read More
Biocon Biologics appoints Shreehas Tambe as MD, CEO
Updated : 3 years, 3 months ago IST
Tambe takes over from Arun Chandavarkar, who will continue to serve as a non-executive, non-independent director on the board of Biocon Biologics.
Read More
Biocon Biologics completes acquisition of Viatris' Global Biosimilars Busi
Updated : 3 years, 3 months ago IST
Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Vi
Read More
Biocon subsidiary completes acquisition of Viatris for USD 3 billion
Updated : 3 years, 3 months ago IST
According to a statement by the pharma company, Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators including the US Federal Trade Commission, the Competition Commission of India and the Reserve Bank of India, and its investors, respectively.
Read More